Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-18 Purchase(A) |
2022-04-20 5:45 pm |
Societal CDMO Inc. | SCTL | AWM Investment Company Inc. n/a |
27,700 | $1.5533 | $43,028 | 5,109,601 (Indirect) |
View |
| 2022-04-18 Purchase |
2022-04-20 4:27 pm |
Societal CDMO Inc. | SCTL | AWM Investment Company Inc. 10% Owner |
27,700 | $1.5533 | $43,028 | 5,109,601 (Indirect) |
View |
| 2022-04-18 Purchase |
2022-04-20 06:37 am |
Societal CDMO Inc. | SCTL | ENLOE J DAVID JR Chief Executive Officer |
625 | $1.63 | $1,019 | 502,914 (Direct) |
View |
| 2022-03-18 Purchase |
2022-03-22 5:32 pm |
Societal CDMO Inc. | SCTL | Miller James Charles Director |
1,000 | $2.145 | $2,145 | 28,923 (Direct) |
View |
| 2022-03-15 Purchase |
2022-03-17 5:33 pm |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
512 | $1.96 | $1,004 | 524,879 (Direct) |
View |
| 2022-02-15 Purchase |
2022-02-17 5:23 pm |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
571 | $1.77 | $1,011 | 524,367 (Direct) |
View |
| 2022-01-18 Purchase |
2022-01-19 4:30 pm |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
602 | $1.68 | $1,011 | 154,759 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 4:42 pm |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
99,398 | $1.5517 | $154,236 | 5,081,901 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-20 4:44 pm |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
50,000 | $1.61 | $80,500 | 5,181,299 (Indirect) |
View |
| 2021-12-15 Purchase |
2021-12-17 7:37 pm |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
617 | $1.61 | $993 | 154,157 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 4:42 pm |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
50,602 | $1.6162 | $81,785 | 5,231,299 (Indirect) |
View |
| 2021-11-17 Purchase |
2021-11-19 5:15 pm |
Recro Pharma Inc. | REPH | Miller James Charles Director |
1,000 | $1.6886 | $1,689 | 27,923 (Direct) |
View |
| 2021-11-12 Purchase |
2021-11-16 06:05 am |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,212 | $1.6477 | $1,997 | 374,385 (Direct) |
View |
| 2021-11-12 Purchase |
2021-11-16 06:05 am |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
1,725 | $1.6784 | $2,895 | 153,540 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 4:22 pm |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
466,667 | $2.2069 | $1,029,891 | 4,419,081 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-20 Tax Withholding |
2022-04-04 5:25 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | ENLOE J DAVID JR Chief Executive Officer |
22,590 | $1.65 | 501,206 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-04-04 5:25 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | Lake Ryan David Chief Financial Officer |
1,197 | $1.66 | 529,052 (Direct) |
View |
| 2022-01-20 Tax Withholding |
2022-04-04 5:25 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | Lake Ryan David Chief Financial Officer |
13,306 | $1.65 | 529,052 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:25 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | Lake Ryan David Chief Financial Officer |
1,198 | $1.8 | 529,052 (Direct) |
View |
| 2022-02-03 Tax Withholding |
2022-02-04 4:41 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,021 | $1.54 | 544,753 (Direct) |
View |
| 2022-01-31 Tax Withholding |
2022-02-02 4:30 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,419 | $1.54 | 545,774 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 9:30 pm |
N/A 2032-01-20 |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
457,089 | $0 | 794,981 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 9:27 pm |
N/A 2032-01-20 |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
811,515 | $0 | 966,274 (Direct) |
View |
| 2022-01-18 Tax Withholding |
2022-01-19 4:31 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,094 | $1.65 | 337,892 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 9:34 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
28,730 | $1.71 | 338,986 (Direct) |
View |
| 2022-01-03 Tax Withholding |
2022-01-04 9:34 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
979 | $1.74 | 338,986 (Direct) |
View |
| 2021-12-15 Tax Withholding |
2021-12-17 7:36 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,690 | $1.61 | 368,695 (Direct) |
View |
Ownership |
2021-11-19 4:15 pm |
N/A N/A |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
0 | $0 | 5,281,901 (Indirect) |
View |
| 2021-07-08 Tax Withholding |
2021-07-13 06:03 am |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,172 | $1.96 | 373,173 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-21 11:56 am |
N/A 2031-06-14 |
Recro Pharma Inc. | REPH | Parks Laura L. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-07 Tax Withholding |
2021-06-08 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
719 | $2.3 | 378,345 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
2,500 | $0 | 378,345 (Direct) |
View |
Ownership |
2021-05-21 4:11 pm |
N/A N/A |
Recro Pharma Inc. | REPH | AWM Investment Company Inc. 10% Owner |
0 | $0 | 4,885,748 (Indirect) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:09 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:09 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:07 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Ashton William Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:07 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:05 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Miller James Charles Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:04 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:03 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:59 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Miller James Charles Director |
64,935 | $0 | 64,935 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:58 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Weisman Wayne Director |
64,935 | $0 | 122,994 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:58 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Reasons Bryan M. Director |
64,935 | $0 | 105,441 (Direct) |
View |